FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ANVAENBARA BENSOPYRANDERIVAT

Compounds of the formula I wherein R1 is hydrogen, halogen, trifluoromethyl, nitro, cyano, lower alkyl, lower alkoxycarbonyl, lower alkylthio, lower alkylsulphonyl, lower alkanoyl, aroyl, carbamoyl, mono(lower alkyl)carbamoyl or di(lower alkyl)carbamoyl, R2 is hydrogen, lower alkyl or phenyl, R3 is hydrogen or lower alkyl, R4 and R5 each is hydrogen or R4 is hydroxy and R5 is hydrogen or R4 and R5 together are a carbon-carbon bond and R6 is an aryl or N-heteroaryl group carrying a hydroxy group in the 2-position or, in the case of a N-heteroaryl group, also a N-oxide group in the 2-position, and pharmaceutically acceptable acid addition salts of these compounds of formula I which are basic, possess pronounced potassium channel activating activity and can be used as medicaments, particularly in the control or prevention of hypertension, congestive heart failure, angina pectoris, peripheral and cerebral vascular disease and smooth muscle disorders.